Liquidia Technologies, Inc.
Liquidia Technologies, Inc.
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 4 | 2026-10-02 | NCT07759804 | |
| A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-02 | NCT07285655 | |
| A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks | Embolism and Thrombosis, Raynaud disease, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, livedoid vasculopathy, peripheral vascular disease, skin disorder, skin vascular disease, systemic sclerosis, thrombotic disease, vascular disorder | Not yet recruiting | Phase 2 | 2026-08-07 | NCT07748000 | |
| The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-07-24 | NCT07561034 | |
| An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-06-26 | NCT06129240 | |
| A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-04-01 | NCT04691154 | |
| Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, connective tissue disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2025-01-29 | NCT03992755 |